Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...

Proprietary Semaglutide + Tirzepatide Dual-Peptide Formulation Now Available Exclusively Through the Tru2u.health PlatformLake Oswego, Portland--(Newsfile Corp. - May 6, 2026) - Functional Brands Inc.

Researchers conducted a phase 3 trial to compare the efficacy and safety of synthetic semaglutide with Ozempic® for glycemic ...

Semaglutide (Ozempic®, Wegovy®, Rybelsus®) comes in both injection and oral form. But beyond how you take it, what’s the difference? And which form is more effective for weight loss? Semaglutide ...

Today, Health Canada authorized a generic semaglutide injection. This is the first generic semaglutide authorized by Health Canada, and the first to be approved in the G7. Health Canada is currently ...

In the ever-evolving landscape of weight management and diabetes treatment, semaglutide has emerged as a significant player. Originally approved by the FDA for managing type 2 diabetes under Ozempic, ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties from compounding the drug. Our FDA/Food, Drug & Device and ...

After May 22, compounding pharmacies can no longer make and sell semaglutide injections. They were initially allowed to because the FDA declared a shortage, but that period has ended. At Melrose ...

Research indicates semaglutide can significantly decrease alcohol consumption and cravings in individuals with comorbid ...

Orbicular Pharmaceutical Technologies, in partnership with Apotex, successfully received Health Canada's Notice of Compliance ...